Transgene Biotek Fair Value
Transgene Biotek (TRABI) average fair value is ₹1.65 across 2 valuation models — P/B Based Valuation, Asset-Based Valuation, vs a current market price of ₹2.56 (-35.74%), fair value range ₹1.32–₹1.97. For live price and a broader fundamental view, visit TRABI share price.
Fair Value Analysis Export
TRABI Fair Value vs Current Price — Valuation Summary
TRABI average fair value, fair value range, price gap and valuation status across 2 models: P/B Based Valuation, Asset-Based Valuation. Explore TRABI investment value to estimate fundamental worth using multiple valuation models.
P/B Based Valuation
Asset-Based Valuation
TRABI Fair Value Analysis — Data Sources & Coverage
Transgene Biotek financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. Examine TRABI Q4 results for recent quarterly revenue, profit and EPS trends.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
TRABI vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
Transgene Biotek P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Suraksha Diagnostic | SURAKSHA | 40.64 | 5.71 | ₹1,356 |
| Deccan Health Care | DECCAN | 12.18 | 0.25 | ₹27 |
| Jupiter Life Line Hospit… | JLHL | 44.49 | 5.79 | ₹8,320 |
| One Global Service Provi… | ONEGLOBAL | 17.94 | 11.02 | ₹1,165 |
| Fortis Healthcare | FORTIS | 65.48 | 6.81 | ₹64,009 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.